CA2988930A1 - Bacteria engineered to treat diseases associated with hyperammonemia - Google Patents

Info

Publication number

CA2988930A1

CA2988930A1 CA2988930A CA2988930A CA2988930A1 CA 2988930 A1 CA2988930 A1 CA 2988930A1 CA 2988930 A CA2988930 A CA 2988930A CA 2988930 A CA2988930 A CA 2988930A CA 2988930 A1 CA2988930 A1 CA 2988930A1

Authority

CA

Canada

Prior art keywords

genetically engineered

gene

bacterium

promoter

engineered bacterium

Prior art date

2015-06-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 241000894006 Bacteria Species 0.000 title claims abstract description 360
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 54
• 206010020575 Hyperammonaemia Diseases 0.000 title claims abstract description 41
• 201000010099 disease Diseases 0.000 title claims description 15
• 238000000034 method Methods 0.000 claims abstract description 28
• 108090000623 proteins and genes Proteins 0.000 claims description 364
• 239000004475 Arginine Substances 0.000 claims description 284
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 283
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 104
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 104
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 76
• 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 claims description 67
• 102000007610 Amino-acid N-acetyltransferase Human genes 0.000 claims description 67
• 102000004190 Enzymes Human genes 0.000 claims description 67
• 108090000790 Enzymes Proteins 0.000 claims description 67
• 229940088598 enzyme Drugs 0.000 claims description 67
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 66
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 50
• 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 49
• 241000588724 Escherichia coli Species 0.000 claims description 48
• 239000001301 oxygen Substances 0.000 claims description 48
• 229910052760 oxygen Inorganic materials 0.000 claims description 48
• 230000001580 bacterial effect Effects 0.000 claims description 46
• 230000002829 reductive effect Effects 0.000 claims description 45
• 239000013612 plasmid Substances 0.000 claims description 42
• 239000011572 manganese Substances 0.000 claims description 41
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 40
• 229910052748 manganese Inorganic materials 0.000 claims description 40
• 230000004888 barrier function Effects 0.000 claims description 39
• 208000035475 disorder Diseases 0.000 claims description 38
• 208000007386 hepatic encephalopathy Diseases 0.000 claims description 38
• 230000007613 environmental effect Effects 0.000 claims description 36
• 239000003623 enhancer Substances 0.000 claims description 32
• 230000005764 inhibitory process Effects 0.000 claims description 31
• 239000002207 metabolite Substances 0.000 claims description 31
• 208000028547 Inborn Urea Cycle disease Diseases 0.000 claims description 27
• 210000000349 chromosome Anatomy 0.000 claims description 27
• 208000030954 urea cycle disease Diseases 0.000 claims description 27
• 108010078791 Carrier Proteins Proteins 0.000 claims description 26
• 102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 claims description 23
• 101150089004 argR gene Proteins 0.000 claims description 17
• 230000015556 catabolic process Effects 0.000 claims description 16
• 208000024891 symptom Diseases 0.000 claims description 16
• 102000003939 Membrane transport proteins Human genes 0.000 claims description 14
• 108090000301 Membrane transport proteins Proteins 0.000 claims description 14
• 238000012217 deletion Methods 0.000 claims description 14
• 230000037430 deletion Effects 0.000 claims description 14
• 241000124008 Mammalia Species 0.000 claims description 11
• 102000014914 Carrier Proteins Human genes 0.000 claims description 10
• 206010067125 Liver injury Diseases 0.000 claims description 10
• 231100000234 hepatic damage Toxicity 0.000 claims description 10
• 230000008818 liver damage Effects 0.000 claims description 10
• 230000007812 deficiency Effects 0.000 claims description 9
• 238000003780 insertion Methods 0.000 claims description 9
• 230000037431 insertion Effects 0.000 claims description 9
• 230000000529 probiotic effect Effects 0.000 claims description 9
• 210000000813 small intestine Anatomy 0.000 claims description 9
• 239000006041 probiotic Substances 0.000 claims description 8
• 235000018291 probiotics Nutrition 0.000 claims description 8
• 241000606125 Bacteroides Species 0.000 claims description 7
• 244000052616 bacterial pathogen Species 0.000 claims description 7
• 238000007254 oxidation reaction Methods 0.000 claims description 7
• 239000007845 reactive nitrogen species Substances 0.000 claims description 7
• 239000003642 reactive oxygen metabolite Substances 0.000 claims description 7
• 241000193403 Clostridium Species 0.000 claims description 6
• 102100023673 Succinate-semialdehyde dehydrogenase, mitochondrial Human genes 0.000 claims description 6
• 208000019423 liver disease Diseases 0.000 claims description 6
• 238000006467 substitution reaction Methods 0.000 claims description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 5
• 241000186660 Lactobacillus Species 0.000 claims description 5
• 229940039696 lactobacillus Drugs 0.000 claims description 5
• 230000003647 oxidation Effects 0.000 claims description 5
• 238000002560 therapeutic procedure Methods 0.000 claims description 5
• 231100000331 toxic Toxicity 0.000 claims description 5
• 230000002588 toxic effect Effects 0.000 claims description 5
• GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 claims description 4
• 241000186000 Bifidobacterium Species 0.000 claims description 4
• 241000282414 Homo sapiens Species 0.000 claims description 4
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 4
• 241000194036 Lactococcus Species 0.000 claims description 4
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 4
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 4
• 206010047700 Vomiting Diseases 0.000 claims description 4
• 230000007547 defect Effects 0.000 claims description 4
• 239000000203 mixture Substances 0.000 claims description 4
• 229960003104 ornithine Drugs 0.000 claims description 4
• 230000008673 vomiting Effects 0.000 claims description 4
• 208000007788 Acute Liver Failure Diseases 0.000 claims description 3
• 206010000804 Acute hepatic failure Diseases 0.000 claims description 3
• 206010062695 Arginase deficiency Diseases 0.000 claims description 3
• 208000034318 Argininemia Diseases 0.000 claims description 3
• 206010058298 Argininosuccinate synthetase deficiency Diseases 0.000 claims description 3
• 206010003591 Ataxia Diseases 0.000 claims description 3
• 201000004569 Blindness Diseases 0.000 claims description 3
• 208000014644 Brain disease Diseases 0.000 claims description 3
• 206010048962 Brain oedema Diseases 0.000 claims description 3
• 206010058297 Carbamoyl phosphate synthetase deficiency Diseases 0.000 claims description 3
• 201000011297 Citrullinemia Diseases 0.000 claims description 3
• 206010010071 Coma Diseases 0.000 claims description 3
• 206010010904 Convulsion Diseases 0.000 claims description 3
• 208000032274 Encephalopathy Diseases 0.000 claims description 3
• 208000010334 End Stage Liver Disease Diseases 0.000 claims description 3
• 101000986595 Homo sapiens Ornithine transcarbamylase, mitochondrial Proteins 0.000 claims description 3
• 206010021113 Hypothermia Diseases 0.000 claims description 3
• 102000003960 Ligases Human genes 0.000 claims description 3
• 108090000364 Ligases Proteins 0.000 claims description 3
• 108700043217 N-acetyl glutamate synthetase deficiency Proteins 0.000 claims description 3
• 208000000599 Ornithine Carbamoyltransferase Deficiency Disease Diseases 0.000 claims description 3
• 206010052450 Ornithine transcarbamoylase deficiency Diseases 0.000 claims description 3
• 208000035903 Ornithine transcarbamylase deficiency Diseases 0.000 claims description 3
• 208000028017 Psychotic disease Diseases 0.000 claims description 3
• 206010038664 Respiratory alkalosis Diseases 0.000 claims description 3
• 208000006011 Stroke Diseases 0.000 claims description 3
• 230000001154 acute effect Effects 0.000 claims description 3
• 231100000836 acute liver failure Toxicity 0.000 claims description 3
• 201000003554 argininosuccinic aciduria Diseases 0.000 claims description 3
• 208000006752 brain edema Diseases 0.000 claims description 3
• 208000011444 chronic liver failure Diseases 0.000 claims description 3
• 201000011286 hyperargininemia Diseases 0.000 claims description 3
• 230000002631 hypothermal effect Effects 0.000 claims description 3
• 208000015181 infectious disease Diseases 0.000 claims description 3
• 230000000968 intestinal effect Effects 0.000 claims description 3
• 230000003902 lesion Effects 0.000 claims description 3
• 239000002773 nucleotide Substances 0.000 claims description 3
• 150000007524 organic acids Chemical class 0.000 claims description 3
• 201000011278 ornithine carbamoyltransferase deficiency Diseases 0.000 claims description 3
• 230000004393 visual impairment Effects 0.000 claims description 3
• 108700005389 3-methylcrotonyl CoA carboxylase 1 deficiency Proteins 0.000 claims description 2
• 201000008000 3-methylcrotonyl-CoA carboxylase deficiency Diseases 0.000 claims description 2
• 108010024976 Asparaginase Proteins 0.000 claims description 2
• 102000015790 Asparaginase Human genes 0.000 claims description 2
• 108090000209 Carbonic anhydrases Proteins 0.000 claims description 2
• 102000003846 Carbonic anhydrases Human genes 0.000 claims description 2
• 206010058892 Carnitine deficiency Diseases 0.000 claims description 2
• 239000004471 Glycine Substances 0.000 claims description 2
• 208000015074 Hyperinsulinism-hyperammonemia syndrome Diseases 0.000 claims description 2
• 208000000420 Isovaleric acidemia Diseases 0.000 claims description 2
• 208000034578 Multiple myelomas Diseases 0.000 claims description 2
• 208000000693 Neurogenic Urinary Bladder Diseases 0.000 claims description 2
• 206010029279 Neurogenic bladder Diseases 0.000 claims description 2
• 208000012868 Overgrowth Diseases 0.000 claims description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
• 208000021886 Pyruvate carboxylase deficiency Diseases 0.000 claims description 2
• 229960003272 asparaginase Drugs 0.000 claims description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims description 2
• 238000010322 bone marrow transplantation Methods 0.000 claims description 2
• 229960004203 carnitine Drugs 0.000 claims description 2
• 238000002512 chemotherapy Methods 0.000 claims description 2
• 238000002574 cystoscopy Methods 0.000 claims description 2
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
• 230000010339 dilation Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 201000002123 familial hyperinsulinemic hypoglycemia 6 Diseases 0.000 claims description 2
• 229930195729 fatty acid Natural products 0.000 claims description 2
• 239000000194 fatty acid Substances 0.000 claims description 2
• 150000004665 fatty acids Chemical class 0.000 claims description 2
• 201000004151 lysinuric protein intolerance Diseases 0.000 claims description 2
• 201000003694 methylmalonic acidemia Diseases 0.000 claims description 2
• 208000012268 mitochondrial disease Diseases 0.000 claims description 2
• 201000004012 propionic acidemia Diseases 0.000 claims description 2
• AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims description 2
• 239000000126 substance Substances 0.000 claims description 2
• 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 claims description 2
• 235000021476 total parenteral nutrition Nutrition 0.000 claims description 2
• 210000000626 ureter Anatomy 0.000 claims description 2
• 208000019206 urinary tract infection Diseases 0.000 claims description 2
• 229940102566 valproate Drugs 0.000 claims description 2
• 229960003692 gamma aminobutyric acid Drugs 0.000 claims 21
• 101710123927 Probable succinate-semialdehyde dehydrogenase [NADP(+)] Proteins 0.000 claims 3
• 101710143049 Succinate-semialdehyde dehydrogenase [NADP(+)] Proteins 0.000 claims 3
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 2
• PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 1
• 241000588722 Escherichia Species 0.000 claims 1
• GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 229940113082 thymine Drugs 0.000 claims 1
• 239000008194 pharmaceutical composition Substances 0.000 abstract description 6
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 304
• 229960003121 arginine Drugs 0.000 description 254
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 253
• 235000009697 arginine Nutrition 0.000 description 253
• 229910021529 ammonia Inorganic materials 0.000 description 148
• 230000015572 biosynthetic process Effects 0.000 description 126
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 103
• 101710149879 Arginine repressor Proteins 0.000 description 97
• 230000001105 regulatory effect Effects 0.000 description 93
• 230000027455 binding Effects 0.000 description 81
• 230000014509 gene expression Effects 0.000 description 81
• 238000004519 manufacturing process Methods 0.000 description 78
• 108090000765 processed proteins & peptides Proteins 0.000 description 76
• 102000004169 proteins and genes Human genes 0.000 description 57
• 235000018102 proteins Nutrition 0.000 description 54
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 50
• 102000004196 processed proteins & peptides Human genes 0.000 description 50
• 210000004027 cell Anatomy 0.000 description 49
• 230000001939 inductive effect Effects 0.000 description 49
• 150000007523 nucleic acids Chemical group 0.000 description 45
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 40
• 229920001184 polypeptide Polymers 0.000 description 40
• 230000035772 mutation Effects 0.000 description 38
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 35
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 35
• 229960002173 citrulline Drugs 0.000 description 35
• 235000013477 citrulline Nutrition 0.000 description 35
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
• 239000006227 byproduct Substances 0.000 description 33
• 102000039446 nucleic acids Human genes 0.000 description 32
• 108020004707 nucleic acids Proteins 0.000 description 32
• 230000028327 secretion Effects 0.000 description 32
• 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 32
• 101150118463 argG gene Proteins 0.000 description 31
• 239000000543 intermediate Substances 0.000 description 29
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 26
• 230000001965 increasing effect Effects 0.000 description 26
• 230000001225 therapeutic effect Effects 0.000 description 26
• 229930195712 glutamate Natural products 0.000 description 25
• -1 e.g. Substances 0.000 description 24
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 22
• 241000699670 Mus sp. Species 0.000 description 22
• 108010002161 N-acetylornithine deacetylase Proteins 0.000 description 22
• 238000013518 transcription Methods 0.000 description 22
• 230000035897 transcription Effects 0.000 description 22
• 230000008520 organization Effects 0.000 description 20
• 102000053640 Argininosuccinate synthases Human genes 0.000 description 19
• 108700024106 Argininosuccinate synthases Proteins 0.000 description 19
• 101710113083 Carbamoyl-phosphate synthase Proteins 0.000 description 19
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 19
• 102000004316 Oxidoreductases Human genes 0.000 description 19
• 108090000854 Oxidoreductases Proteins 0.000 description 19
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 19
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 19
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 19
• 244000005700 microbiome Species 0.000 description 19
• 229910052757 nitrogen Inorganic materials 0.000 description 19
• 241000894007 species Species 0.000 description 19
• 108700021045 Acetylglutamate kinase Proteins 0.000 description 18
• BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 18
• 108091028043 Nucleic acid sequence Proteins 0.000 description 18
• 102000001253 Protein Kinase Human genes 0.000 description 18
• 230000001147 anti-toxic effect Effects 0.000 description 18
• 101150072344 argA gene Proteins 0.000 description 18
• 239000003053 toxin Substances 0.000 description 18
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 17
• 125000003275 alpha amino acid group Chemical group 0.000 description 17
• 235000001014 amino acid Nutrition 0.000 description 17
• 230000001419 dependent effect Effects 0.000 description 17
• OJJHFKVRJCQKLN-YFKPBYRVSA-N (4s)-4-acetamido-5-oxo-5-phosphonooxypentanoic acid Chemical compound OC(=O)CC[C@H](NC(=O)C)C(=O)OP(O)(O)=O OJJHFKVRJCQKLN-YFKPBYRVSA-N 0.000 description 16
• 101710191958 Amino-acid acetyltransferase Proteins 0.000 description 16
• 102000009042 Argininosuccinate Lyase Human genes 0.000 description 16
• 229960002743 glutamine Drugs 0.000 description 16
• 230000037361 pathway Effects 0.000 description 16
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 16
• 231100000765 toxin Toxicity 0.000 description 16
• 108700012359 toxins Proteins 0.000 description 16
• 229940024606 amino acid Drugs 0.000 description 15
• 150000001413 amino acids Chemical class 0.000 description 15
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 15
• 235000004554 glutamine Nutrition 0.000 description 15
• 241000370685 Arge Species 0.000 description 14
• 101150054092 buk gene Proteins 0.000 description 14
• 238000000338 in vitro Methods 0.000 description 14
• 230000001404 mediated effect Effects 0.000 description 14
• 230000032258 transport Effects 0.000 description 14
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 13
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 13
• 239000004472 Lysine Substances 0.000 description 13
• 102000040945 Transcription factor Human genes 0.000 description 13
• 108091023040 Transcription factor Proteins 0.000 description 13
• 230000003115 biocidal effect Effects 0.000 description 13
• 230000000694 effects Effects 0.000 description 13
• 235000018977 lysine Nutrition 0.000 description 13
• 230000004048 modification Effects 0.000 description 13
• 238000012986 modification Methods 0.000 description 13
• 150000004666 short chain fatty acids Chemical class 0.000 description 13
• 101150026728 tesB gene Proteins 0.000 description 13
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 12
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 12
• 101100217185 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aruC gene Proteins 0.000 description 12
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 12
• 230000000447 dimerizing effect Effects 0.000 description 12
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 12
• 229960002885 histidine Drugs 0.000 description 12
• 235000014304 histidine Nutrition 0.000 description 12
• 229960004452 methionine Drugs 0.000 description 12
• 229930101283 tetracycline Natural products 0.000 description 12
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 11
• 210000004369 blood Anatomy 0.000 description 11
• 239000008280 blood Substances 0.000 description 11
• 230000006698 induction Effects 0.000 description 11
• 229930182817 methionine Natural products 0.000 description 11
• 235000006109 methionine Nutrition 0.000 description 11
• 238000011282 treatment Methods 0.000 description 11
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 10
• 235000014469 Bacillus subtilis Nutrition 0.000 description 10
• 101100022072 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) lysJ gene Proteins 0.000 description 10
• 101100323865 Xenopus laevis arg1 gene Proteins 0.000 description 10
• 101150050866 argD gene Proteins 0.000 description 10
• 229960001230 asparagine Drugs 0.000 description 10
• 235000009582 asparagine Nutrition 0.000 description 10
• 239000012634 fragment Substances 0.000 description 10
• 108010050322 glutamate acetyltransferase Proteins 0.000 description 10
• 230000000670 limiting effect Effects 0.000 description 10
• 239000012528 membrane Substances 0.000 description 10
• 231100000252 nontoxic Toxicity 0.000 description 10
• 230000003000 nontoxic effect Effects 0.000 description 10
• 101710165738 Acetylornithine aminotransferase Proteins 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 206010061218 Inflammation Diseases 0.000 description 9
• 230000003213 activating effect Effects 0.000 description 9
• 101150070764 carB gene Proteins 0.000 description 9
• 238000006243 chemical reaction Methods 0.000 description 9
• 230000002759 chromosomal effect Effects 0.000 description 9
• 230000003247 decreasing effect Effects 0.000 description 9
• 239000005090 green fluorescent protein Substances 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 230000004054 inflammatory process Effects 0.000 description 9
• 108020004999 messenger RNA Proteins 0.000 description 9
• 108010048816 AraC Transcription Factor Proteins 0.000 description 8
• 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 8
• 208000023105 Huntington disease Diseases 0.000 description 8
• JRLGPAXAGHMNOL-LURJTMIESA-N N(2)-acetyl-L-ornithine Chemical compound CC(=O)N[C@H](C([O-])=O)CCC[NH3+] JRLGPAXAGHMNOL-LURJTMIESA-N 0.000 description 8
• 239000004098 Tetracycline Substances 0.000 description 8
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
• 101150008194 argB gene Proteins 0.000 description 8
• 238000010586 diagram Methods 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 230000028709 inflammatory response Effects 0.000 description 8
• 101150039489 lysZ gene Proteins 0.000 description 8
• 229960005322 streptomycin Drugs 0.000 description 8
• 239000000758 substrate Substances 0.000 description 8
• 229960002180 tetracycline Drugs 0.000 description 8
• 235000019364 tetracycline Nutrition 0.000 description 8
• 150000003522 tetracyclines Chemical class 0.000 description 8
• 244000063299 Bacillus subtilis Species 0.000 description 7
• 101100096227 Bacteroides fragilis (strain 638R) argF' gene Proteins 0.000 description 7
• 241000193163 Clostridioides difficile Species 0.000 description 7
• 101100163308 Clostridium perfringens (strain 13 / Type A) argR1 gene Proteins 0.000 description 7
• 108020004705 Codon Proteins 0.000 description 7
• 102100023795 Elafin Human genes 0.000 description 7
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 7
• 101100354186 Mycoplasma capricolum subsp. capricolum (strain California kid / ATCC 27343 / NCTC 10154) ptcA gene Proteins 0.000 description 7
• 101150070427 argC gene Proteins 0.000 description 7
• 101150089042 argC2 gene Proteins 0.000 description 7
• 101150056313 argF gene Proteins 0.000 description 7
• 238000001784 detoxification Methods 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• 239000003814 drug Substances 0.000 description 7
• 230000002708 enhancing effect Effects 0.000 description 7
• 108020001507 fusion proteins Proteins 0.000 description 7
• 102000037865 fusion proteins Human genes 0.000 description 7
• 108020002326 glutamine synthetase Proteins 0.000 description 7
• 210000002429 large intestine Anatomy 0.000 description 7
• 101150094164 lysY gene Proteins 0.000 description 7
• 230000008569 process Effects 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 101150061166 tetR gene Proteins 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 6
• 108091026922 FnrS RNA Proteins 0.000 description 6
• 102000009661 Repressor Proteins Human genes 0.000 description 6
• 108090000340 Transaminases Proteins 0.000 description 6
• 102000003929 Transaminases Human genes 0.000 description 6
• 101150029940 argJ gene Proteins 0.000 description 6
• 210000003578 bacterial chromosome Anatomy 0.000 description 6
• 230000001851 biosynthetic effect Effects 0.000 description 6
• 230000001628 butyrogenic effect Effects 0.000 description 6
• 102000005396 glutamine synthetase Human genes 0.000 description 6
• 230000002401 inhibitory effect Effects 0.000 description 6
• 210000004185 liver Anatomy 0.000 description 6
• 230000009467 reduction Effects 0.000 description 6
• 101150072314 thyA gene Proteins 0.000 description 6
• 230000002103 transcriptional effect Effects 0.000 description 6
• 230000004143 urea cycle Effects 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 101100427060 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) thyA1 gene Proteins 0.000 description 5
• 241000131329 Carabidae Species 0.000 description 5
• 108700010070 Codon Usage Proteins 0.000 description 5
• 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 description 5
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
• 101100153154 Escherichia phage T5 thy gene Proteins 0.000 description 5
• 108700039887 Essential Genes Proteins 0.000 description 5
• 108091006228 GABA transporters Proteins 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 240000006024 Lactobacillus plantarum Species 0.000 description 5
• 108010034634 Repressor Proteins Proteins 0.000 description 5
• 101100313751 Rickettsia conorii (strain ATCC VR-613 / Malish 7) thyX gene Proteins 0.000 description 5
• 101150054318 argH gene Proteins 0.000 description 5
• 108091006374 cAMP receptor proteins Proteins 0.000 description 5
• 101150014229 carA gene Proteins 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 235000005911 diet Nutrition 0.000 description 5
• 230000037213 diet Effects 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 229930027917 kanamycin Natural products 0.000 description 5
• 229960000318 kanamycin Drugs 0.000 description 5
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
• 229930182823 kanamycin A Natural products 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 125000004433 nitrogen atom Chemical group N* 0.000 description 5
• 239000011541 reaction mixture Substances 0.000 description 5
• 230000005945 translocation Effects 0.000 description 5
• 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 4
• 101100404144 Bacillus subtilis (strain 168) nasD gene Proteins 0.000 description 4
• 241000186016 Bifidobacterium bifidum Species 0.000 description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
• 102000037078 GABA transporters Human genes 0.000 description 4
• 101001048718 Homo sapiens Elafin Proteins 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• 240000001046 Lactobacillus acidophilus Species 0.000 description 4
• 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 4
• 235000013965 Lactobacillus plantarum Nutrition 0.000 description 4
• 108010076504 Protein Sorting Signals Proteins 0.000 description 4
• 241000607142 Salmonella Species 0.000 description 4
• 101100028324 Streptomyces rimosus subsp. rimosus (strain ATCC 10970 / DSM 40260 / JCM 4667 / NRRL 2234) oxyS gene Proteins 0.000 description 4
• 108020004566 Transfer RNA Proteins 0.000 description 4
• 241000700605 Viruses Species 0.000 description 4
• 230000004913 activation Effects 0.000 description 4
• 229940002008 bifidobacterium bifidum Drugs 0.000 description 4
• 239000004202 carbamide Substances 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 229920003045 dextran sodium sulfate Polymers 0.000 description 4
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
• 230000002550 fecal effect Effects 0.000 description 4
• 101150106794 gabP gene Proteins 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• 101150032598 hisG gene Proteins 0.000 description 4
• HCZHHEIFKROPDY-UHFFFAOYSA-N kynurenic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC(=O)C2=C1 HCZHHEIFKROPDY-UHFFFAOYSA-N 0.000 description 4
• YGPSJZOEDVAXAB-UHFFFAOYSA-N kynurenine Chemical compound OC(=O)C(N)CC(=O)C1=CC=CC=C1N YGPSJZOEDVAXAB-UHFFFAOYSA-N 0.000 description 4
• 229940039695 lactobacillus acidophilus Drugs 0.000 description 4
• 229940072205 lactobacillus plantarum Drugs 0.000 description 4
• 101150040895 metJ gene Proteins 0.000 description 4
• 230000002503 metabolic effect Effects 0.000 description 4
• 230000037353 metabolic pathway Effects 0.000 description 4
• 230000000813 microbial effect Effects 0.000 description 4
• 101150041177 mntH gene Proteins 0.000 description 4
• 101150044129 nirB gene Proteins 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 239000000523 sample Substances 0.000 description 4
• 210000002784 stomach Anatomy 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 4
• 230000014616 translation Effects 0.000 description 4
• KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 3
• 241000606124 Bacteroides fragilis Species 0.000 description 3
• 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 3
• 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 3
• 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 3
• 241000193171 Clostridium butyricum Species 0.000 description 3
• 230000007067 DNA methylation Effects 0.000 description 3
• 108700034853 E coli TRPR Proteins 0.000 description 3
• 108010015972 Elafin Proteins 0.000 description 3
• 241000194031 Enterococcus faecium Species 0.000 description 3
• 241001646716 Escherichia coli K-12 Species 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 3
• 244000199885 Lactobacillus bulgaricus Species 0.000 description 3
• 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 3
• 241000186605 Lactobacillus paracasei Species 0.000 description 3
• 241000186604 Lactobacillus reuteri Species 0.000 description 3
• 101100161530 Mus musculus Acsbg1 gene Proteins 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
• 102000018120 Recombinases Human genes 0.000 description 3
• 108010091086 Recombinases Proteins 0.000 description 3
• 241000235070 Saccharomyces Species 0.000 description 3
• 244000057717 Streptococcus lactis Species 0.000 description 3
• 235000014897 Streptococcus lactis Nutrition 0.000 description 3
• 108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 3
• 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 3
• 108010069584 Type III Secretion Systems Proteins 0.000 description 3
• 101150015189 aceE gene Proteins 0.000 description 3
• 101150077561 aceF gene Proteins 0.000 description 3
• 101150044616 araC gene Proteins 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 229940004120 bifidobacterium infantis Drugs 0.000 description 3
• 229940009289 bifidobacterium lactis Drugs 0.000 description 3
• 230000008238 biochemical pathway Effects 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 3
• 230000007882 cirrhosis Effects 0.000 description 3
• 208000019425 cirrhosis of liver Diseases 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000003776 cleavage reaction Methods 0.000 description 3
• 210000001072 colon Anatomy 0.000 description 3
• 210000000805 cytoplasm Anatomy 0.000 description 3
• 230000002939 deleterious effect Effects 0.000 description 3
• MDCUNMLZLNGCQA-HWOAGHQOSA-N elafin Chemical compound N([C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]2CSSC[C@H]3C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CSSC[C@H]4C(=O)N5CCC[C@H]5C(=O)NCC(=O)N[C@H](C(N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]5N(CCC5)C(=O)[C@H]5N(CCC5)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC2=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N4)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N3)=O)[C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N MDCUNMLZLNGCQA-HWOAGHQOSA-N 0.000 description 3
• 230000003371 gabaergic effect Effects 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000009931 harmful effect Effects 0.000 description 3
• 235000008085 high protein diet Nutrition 0.000 description 3
• TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 210000000936 intestine Anatomy 0.000 description 3
• 108010067653 lactate dehydratase Proteins 0.000 description 3
• 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
• 229940001882 lactobacillus reuteri Drugs 0.000 description 3
• 101150040445 lpd gene Proteins 0.000 description 3
• 101150003321 lpdA gene Proteins 0.000 description 3
• 101150007808 lpdC gene Proteins 0.000 description 3
• WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
• 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
• 101150035558 nuoB gene Proteins 0.000 description 3
• 238000005457 optimization Methods 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 230000007170 pathology Effects 0.000 description 3
• 238000003753 real-time PCR Methods 0.000 description 3
• 229960002181 saccharomyces boulardii Drugs 0.000 description 3
• 230000007017 scission Effects 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• 101150072448 thrB gene Proteins 0.000 description 3
• 101150000850 thrC gene Proteins 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 2
• KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 2
• UIUJIQZEACWQSV-UHFFFAOYSA-M 4-oxobutanoate Chemical compound [O-]C(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-M 0.000 description 2
• 101100235003 Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1) lctC gene Proteins 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• 101100288530 Anaerotignum propionicum lcdA gene Proteins 0.000 description 2
• 101100288531 Anaerotignum propionicum lcdB gene Proteins 0.000 description 2
• 101100288532 Anaerotignum propionicum lcdC gene Proteins 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 241000193749 Bacillus coagulans Species 0.000 description 2
• 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 2
• 241001608472 Bifidobacterium longum Species 0.000 description 2
• 208000033910 Carbamoyl-phosphate synthetase 1 deficiency Diseases 0.000 description 2
• 101100506210 Clostridioides difficile hadC gene Proteins 0.000 description 2
• 101100506213 Clostridioides difficile hadI gene Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 2
• 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 2
• 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 2
• 101150110799 ETFA gene Proteins 0.000 description 2
• 241000194033 Enterococcus Species 0.000 description 2
• 101100394050 Escherichia coli (strain K12) gyrB gene Proteins 0.000 description 2
• 241000192125 Firmicutes Species 0.000 description 2
• 102000005915 GABA Receptors Human genes 0.000 description 2
• 108010005551 GABA Receptors Proteins 0.000 description 2
• 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
• 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 2
• 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 2
• 102000016901 Glutamate dehydrogenase Human genes 0.000 description 2
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
• 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
• 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 2
• 101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• 244000199866 Lactobacillus casei Species 0.000 description 2
• 235000013958 Lactobacillus casei Nutrition 0.000 description 2
• 241001468157 Lactobacillus johnsonii Species 0.000 description 2
• 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
• 208000008457 Neurologic Manifestations Diseases 0.000 description 2
• 108091081548 Palindromic sequence Proteins 0.000 description 2
• 101100026007 Paulinella chromatophora ndhK gene Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
• 241000191940 Staphylococcus Species 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102000007641 Trefoil Factors Human genes 0.000 description 2
• 108010007389 Trefoil Factors Proteins 0.000 description 2
• 241000589892 Treponema denticola Species 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 108010073429 Type V Secretion Systems Proteins 0.000 description 2
• 108010046179 Type VI Secretion Systems Proteins 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 102000005421 acetyltransferase Human genes 0.000 description 2
• 108020002494 acetyltransferase Proteins 0.000 description 2
• 101150004068 acrB gene Proteins 0.000 description 2
• 101150068316 acrC gene Proteins 0.000 description 2
• 108010041620 acryloyl-CoA reductase Proteins 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 238000013019 agitation Methods 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 108700003859 araC Genes Proteins 0.000 description 2
• 101150094408 argI gene Proteins 0.000 description 2
• KDZOASGQNOPSCU-UHFFFAOYSA-N argininosuccinate Chemical compound OC(=O)C(N)CCCN=C(N)NC(C(O)=O)CC(O)=O KDZOASGQNOPSCU-UHFFFAOYSA-N 0.000 description 2
• 101150024707 astC gene Proteins 0.000 description 2
• 210000001130 astrocyte Anatomy 0.000 description 2
• 229940054340 bacillus coagulans Drugs 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 229940009291 bifidobacterium longum Drugs 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 208000022843 carbamoyl phosphate synthetase I deficiency disease Diseases 0.000 description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 description 2
• 210000004534 cecum Anatomy 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 238000011461 current therapy Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 210000003238 esophagus Anatomy 0.000 description 2
• 210000001723 extracellular space Anatomy 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 230000005714 functional activity Effects 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 238000003304 gavage Methods 0.000 description 2
• 238000012224 gene deletion Methods 0.000 description 2
• 235000021472 generally recognized as safe Nutrition 0.000 description 2
• 210000004907 gland Anatomy 0.000 description 2
• TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
• 239000003228 hemolysin Substances 0.000 description 2
• 101150063051 hom gene Proteins 0.000 description 2
• 101150095957 ilvA gene Proteins 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000004968 inflammatory condition Effects 0.000 description 2
• 229940100601 interleukin-6 Drugs 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 229940017800 lactobacillus casei Drugs 0.000 description 2
• 230000005976 liver dysfunction Effects 0.000 description 2
• 238000011866 long-term treatment Methods 0.000 description 2
• 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
• 229960003646 lysine Drugs 0.000 description 2
• 229960003987 melatonin Drugs 0.000 description 2
• DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 239000006151 minimal media Substances 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 239000002858 neurotransmitter agent Substances 0.000 description 2
• 101150103941 nuoBCD gene Proteins 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 230000007918 pathogenicity Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 238000007747 plating Methods 0.000 description 2
• 231100000614 poison Toxicity 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000000644 propagated effect Effects 0.000 description 2
• BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 2
• BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 108010054624 red fluorescent protein Proteins 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
• YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 description 2
• DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
• 101150014006 thrA gene Proteins 0.000 description 2
• 239000003440 toxic substance Substances 0.000 description 2
• 101150006320 trpR gene Proteins 0.000 description 2
• 229960004799 tryptophan Drugs 0.000 description 2
• 102000003390 tumor necrosis factor Human genes 0.000 description 2
• 210000002438 upper gastrointestinal tract Anatomy 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
• CCWGVBYAMXWVBI-JEDNCBNOSA-N (2s)-2-acetamidopentanedioic acid;phosphoric acid Chemical compound OP(O)(O)=O.CC(=O)N[C@H](C(O)=O)CCC(O)=O CCWGVBYAMXWVBI-JEDNCBNOSA-N 0.000 description 1
• MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 1
• PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
• VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
• OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 1
• 108010055682 3-hydroxybutyryl-CoA dehydrogenase Proteins 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 108010058756 ATP phosphoribosyltransferase Proteins 0.000 description 1
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
• 241001430271 Acetitomaculum Species 0.000 description 1
• 241001112780 Acetoanaerobium Species 0.000 description 1
• 241001135190 Acetohalobium Species 0.000 description 1
• 241000204396 Acetonema Species 0.000 description 1
• 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 description 1
• 102000005345 Acetyl-CoA C-acetyltransferase Human genes 0.000 description 1
• 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• 101710120269 Acyl-CoA thioester hydrolase YbgC Proteins 0.000 description 1
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
• 108010082126 Alanine transaminase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 241001136167 Anaerotignum propionicum Species 0.000 description 1
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
• 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 1
• 101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 1
• 101100326957 Bacillus subtilis (strain 168) catD gene Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 108700024126 Butyrate kinases Proteins 0.000 description 1
• 241000605902 Butyrivibrio Species 0.000 description 1
• 108010068197 Butyryl-CoA Dehydrogenase Proteins 0.000 description 1
• 101100339117 Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) hisF1 gene Proteins 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
• 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 238000007702 DNA assembly Methods 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 208000012661 Dyskinesia Diseases 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 101710105586 Electron transfer flavoprotein subunit alpha Proteins 0.000 description 1
• 102100030695 Electron transfer flavoprotein subunit alpha, mitochondrial Human genes 0.000 description 1
• 102100027262 Electron transfer flavoprotein subunit beta Human genes 0.000 description 1
• 101710186952 Electron transfer flavoprotein subunit beta Proteins 0.000 description 1
• 108010079426 Electron-Transferring Flavoproteins Proteins 0.000 description 1
• 102000012737 Electron-Transferring Flavoproteins Human genes 0.000 description 1
• 108010023922 Enoyl-CoA hydratase Proteins 0.000 description 1
• 102000011426 Enoyl-CoA hydratase Human genes 0.000 description 1
• 241000701832 Enterobacteria phage T3 Species 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 101100337717 Escherichia coli (strain K12) grcA gene Proteins 0.000 description 1
• 241001302654 Escherichia coli Nissle 1917 Species 0.000 description 1
• 241000186394 Eubacterium Species 0.000 description 1
• 108010046335 Ferredoxin-NADP Reductase Proteins 0.000 description 1
• 108050000784 Ferritin Proteins 0.000 description 1
• 102000008857 Ferritin Human genes 0.000 description 1
• 238000008416 Ferritin Methods 0.000 description 1
• MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical class [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 241000605909 Fusobacterium Species 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 108050001280 GABA permeases Proteins 0.000 description 1
• 102000027484 GABAA receptors Human genes 0.000 description 1
• 108091008681 GABAA receptors Proteins 0.000 description 1
• 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
• 108020000311 Glutamate Synthase Proteins 0.000 description 1
• 108010073324 Glutaminase Proteins 0.000 description 1
• 102000009127 Glutaminase Human genes 0.000 description 1
• 208000007698 Gyrate Atrophy Diseases 0.000 description 1
• 208000034596 Gyrate atrophy of choroid and retina Diseases 0.000 description 1
• 101100508941 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) ppa gene Proteins 0.000 description 1
• 102100039894 Hemoglobin subunit delta Human genes 0.000 description 1
• 108010006464 Hemolysin Proteins Proteins 0.000 description 1
• 206010019663 Hepatic failure Diseases 0.000 description 1
• 108010064711 Homoserine dehydrogenase Proteins 0.000 description 1
• 206010021036 Hyponatraemia Diseases 0.000 description 1
• 208000001019 Inborn Errors Metabolism Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 208000015592 Involuntary movements Diseases 0.000 description 1
• 206010022998 Irritability Diseases 0.000 description 1
• 102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• 229930195722 L-methionine Natural products 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
• 102100023162 L-serine dehydratase/L-threonine deaminase Human genes 0.000 description 1
• 101710193388 L-serine dehydratase/L-threonine deaminase Proteins 0.000 description 1
• 101710125839 L-threonine dehydratase Proteins 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
• 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
• 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 1
• 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 1
• 102000004317 Lyases Human genes 0.000 description 1
• 108090000856 Lyases Proteins 0.000 description 1
• 241000604448 Megasphaera elsdenii Species 0.000 description 1
• 102000018897 Membrane Fusion Proteins Human genes 0.000 description 1
• 108010027796 Membrane Fusion Proteins Proteins 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• 241000162311 Moritella profunda Species 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 241000699666 Mus <mouse, genus> Species 0.000 description 1
• 101001023834 Mus musculus Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 1
• 208000002740 Muscle Rigidity Diseases 0.000 description 1
• 101100178822 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) htrA1 gene Proteins 0.000 description 1
• RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 206010029155 Nephropathy toxic Diseases 0.000 description 1
• 108090000913 Nitrate Reductases Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 101710113020 Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
• 101710116435 Outer membrane protein Proteins 0.000 description 1
• 241000178986 Oxobacter Species 0.000 description 1
• 101150032327 PI3 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 241001607889 Peptoclostridium Species 0.000 description 1
• 108700024327 Phosphate butyryltransferases Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 208000002389 Pouchitis Diseases 0.000 description 1
• 241000605860 Prevotella ruminicola Species 0.000 description 1
• 241000350158 Prioria balsamifera Species 0.000 description 1
• 102000018819 Protein Translocation Systems Human genes 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 101100277437 Rhizobium meliloti (strain 1021) degP1 gene Proteins 0.000 description 1
• 241001468001 Salmonella virus SP6 Species 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 101710170075 Serine dehydratase-like Proteins 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000607762 Shigella flexneri Species 0.000 description 1
• 241000204388 Sporomusa Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241000187433 Streptomyces clavuligerus Species 0.000 description 1
• 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
• 241001234687 Thermacetogenium Species 0.000 description 1
• 241000204652 Thermotoga Species 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
• 108091036408 Toxin-antitoxin system Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 108010058153 Twin-Arginine-Translocation System Proteins 0.000 description 1
• 108010064721 Type I Secretion Systems Proteins 0.000 description 1
• 108010046504 Type IV Secretion Systems Proteins 0.000 description 1
• 108010050970 Type VII Secretion Systems Proteins 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000000789 acetogenic effect Effects 0.000 description 1
• 229940100228 acetyl coenzyme a Drugs 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 108010069175 acyl-CoA transferase Proteins 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000009603 aerobic growth Effects 0.000 description 1
• 101150061301 ahpF gene Proteins 0.000 description 1
• 230000003281 allosteric effect Effects 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000003862 amino acid derivatives Chemical class 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 230000037354 amino acid metabolism Effects 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 210000002255 anal canal Anatomy 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000002529 anti-mitochondrial effect Effects 0.000 description 1
• 230000003460 anti-nuclear Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 239000000164 antipsychotic agent Substances 0.000 description 1
• 210000000436 anus Anatomy 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 101150017736 araD gene Proteins 0.000 description 1
• 101150042295 arfA gene Proteins 0.000 description 1
• 150000001483 arginine derivatives Chemical class 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 210000004227 basal ganglia Anatomy 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229940049706 benzodiazepine Drugs 0.000 description 1
• 150000001557 benzodiazepines Chemical class 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000008499 blood brain barrier function Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 229940019700 blood coagulation factors Drugs 0.000 description 1
• 210000001218 blood-brain barrier Anatomy 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 230000003925 brain function Effects 0.000 description 1
• NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
• 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• FFQKYPRQEYGKAF-UHFFFAOYSA-N carbamoyl phosphate Chemical compound NC(=O)OP(O)(O)=O FFQKYPRQEYGKAF-UHFFFAOYSA-N 0.000 description 1
• 230000001654 carbamoyl phosphate biosynthesis Effects 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 235000011089 carbon dioxide Nutrition 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 230000003788 cerebral perfusion Effects 0.000 description 1
• 229910052729 chemical element Inorganic materials 0.000 description 1
• 108091006116 chimeric peptides Proteins 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
• 230000004087 circulation Effects 0.000 description 1
• DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
• 229960003120 clonazepam Drugs 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000006999 cognitive decline Effects 0.000 description 1
• 208000010877 cognitive disease Diseases 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 101150018266 degP gene Proteins 0.000 description 1
• 101150083941 degS gene Proteins 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• BABWHSBPEIVBBZ-UHFFFAOYSA-N diazete Chemical compound C1=CN=N1 BABWHSBPEIVBBZ-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 210000003495 flagella Anatomy 0.000 description 1
• 101150077334 focA gene Proteins 0.000 description 1
• 238000005755 formation reaction Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 229960002815 glycerol phenylbutyrate Drugs 0.000 description 1
• ZSDBFLMJVAGKOU-UHFFFAOYSA-N glycerol phenylbutyrate Chemical compound C=1C=CC=CC=1CCCC(=O)OCC(OC(=O)CCCC=1C=CC=CC=1)COC(=O)CCCC1=CC=CC=C1 ZSDBFLMJVAGKOU-UHFFFAOYSA-N 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 101150107068 gsiB gene Proteins 0.000 description 1
• 229960003878 haloperidol Drugs 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 230000007407 health benefit Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 101150107671 hisB gene Proteins 0.000 description 1
• 101150113423 hisD gene Proteins 0.000 description 1
• 101150096813 hisF gene Proteins 0.000 description 1
• 101150041770 hlyE gene Proteins 0.000 description 1
• 230000003284 homeostatic effect Effects 0.000 description 1
• 108010071598 homoserine kinase Proteins 0.000 description 1
• 101150099805 htpG gene Proteins 0.000 description 1
• 210000003405 ileum Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000008676 import Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 208000016245 inborn errors of metabolism Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 208000015978 inherited metabolic disease Diseases 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 239000002054 inoculum Substances 0.000 description 1
• 229910001872 inorganic gas Inorganic materials 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 230000010226 intestinal metabolism Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 238000009533 lab test Methods 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical compound CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 description 1
• 229960004002 levetiracetam Drugs 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 208000007903 liver failure Diseases 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 235000020905 low-protein-diet Nutrition 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 238000013178 mathematical model Methods 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 231100000536 menstrual disturbance Toxicity 0.000 description 1
• 230000006371 metabolic abnormality Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 244000000010 microbial pathogen Species 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 101150056725 narX gene Proteins 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 101150106215 ndh gene Proteins 0.000 description 1
• 230000007694 nephrotoxicity Effects 0.000 description 1
• 231100000417 nephrotoxicity Toxicity 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 101150021871 norC gene Proteins 0.000 description 1
• 235000003715 nutritional status Nutrition 0.000 description 1
• 101150087557 omcB gene Proteins 0.000 description 1
• 101150115693 ompA gene Proteins 0.000 description 1
• 101150110245 ompC gene Proteins 0.000 description 1
• 101150073640 ompF gene Proteins 0.000 description 1
• 238000003305 oral gavage Methods 0.000 description 1
• 208000014380 ornithine aminotransferase deficiency Diseases 0.000 description 1
• 101150008884 osmY gene Proteins 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 101150038927 pdhR gene Proteins 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 101150004519 pilC gene Proteins 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000001376 precipitating effect Effects 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000013615 primer Substances 0.000 description 1
• 238000011165 process development Methods 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 235000021075 protein intake Nutrition 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000012372 quality testing Methods 0.000 description 1
• 229960004431 quetiapine Drugs 0.000 description 1
• URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 229960001534 risperidone Drugs 0.000 description 1
• RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
• 230000002000 scavenging effect Effects 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 235000021391 short chain fatty acids Nutrition 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 229960003885 sodium benzoate Drugs 0.000 description 1
• 229960002232 sodium phenylbutyrate Drugs 0.000 description 1
• VPZRWNZGLKXFOE-UHFFFAOYSA-M sodium phenylbutyrate Chemical compound [Na+].[O-]C(=O)CCCC1=CC=CC=C1 VPZRWNZGLKXFOE-UHFFFAOYSA-M 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 229940032147 starch Drugs 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 230000001502 supplementing effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 230000001839 systemic circulation Effects 0.000 description 1
• 101150019205 tdcD gene Proteins 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 229960005333 tetrabenazine Drugs 0.000 description 1
• 229960002898 threonine Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 101150061964 tolA gene Proteins 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000041 toxicology testing Toxicity 0.000 description 1
• 229910021654 trace metal Inorganic materials 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 230000037426 transcriptional repression Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229940045136 urea Drugs 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 239000000304 virulence factor Substances 0.000 description 1
• 230000007923 virulence factor Effects 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• 101150096946 ydfZ gene Proteins 0.000 description 1